These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


101 related items for PubMed ID: 15355939

  • 1. Effect of n-octanesulphonylacetamide (OSA) on ATP and protein expression in Mycobacterium bovis BCG.
    Parrish NM, Ko CG, Hughes MA, Townsend CA, Dick JD.
    J Antimicrob Chemother; 2004 Oct; 54(4):722-9. PubMed ID: 15355939
    [Abstract] [Full Text] [Related]

  • 2. In vitro activity of a novel antimycobacterial compound, N-octanesulfonylacetamide, and its effects on lipid and mycolic acid synthesis.
    Parrish NM, Houston T, Jones PB, Townsend C, Dick JD.
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1143-50. PubMed ID: 11257028
    [Abstract] [Full Text] [Related]

  • 3. Role for malonyl coenzyme A:acyl carrier protein transacylase (MCAT) in the growth-inhibitory effect of the calmodulin antagonist trifluoperazine in Mycobacterium bovis BCG.
    Sinha I, Dick T.
    J Antimicrob Chemother; 2004 Jun; 53(6):1072-5. PubMed ID: 15150177
    [Abstract] [Full Text] [Related]

  • 4. Global transcriptome analysis of the Mycobacterium bovis BCG response to sodium hypochlorite.
    Jang HJ, Nde C, Toghrol F, Bentley WE.
    Appl Microbiol Biotechnol; 2009 Nov; 85(1):127-40. PubMed ID: 19756581
    [Abstract] [Full Text] [Related]

  • 5. Dual inhibition of mycobacterial fatty acid biosynthesis and degradation by 2-alkynoic acids.
    Morbidoni HR, Vilchèze C, Kremer L, Bittman R, Sacchettini JC, Jacobs WR.
    Chem Biol; 2006 Mar; 13(3):297-307. PubMed ID: 16638535
    [Abstract] [Full Text] [Related]

  • 6. ATP synthase in slow- and fast-growing mycobacteria is active in ATP synthesis and blocked in ATP hydrolysis direction.
    Haagsma AC, Driessen NN, Hahn MM, Lill H, Bald D.
    FEMS Microbiol Lett; 2010 Dec; 313(1):68-74. PubMed ID: 21039782
    [Abstract] [Full Text] [Related]

  • 7. Two distinct proton binding sites in the ATP synthase family.
    von Ballmoos C, Dimroth P.
    Biochemistry; 2007 Oct 23; 46(42):11800-9. PubMed ID: 17910472
    [Abstract] [Full Text] [Related]

  • 8. The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutol.
    Colangeli R, Helb D, Sridharan S, Sun J, Varma-Basil M, Hazbón MH, Harbacheuski R, Megjugorac NJ, Jacobs WR, Holzenburg A, Sacchettini JC, Alland D.
    Mol Microbiol; 2005 Mar 23; 55(6):1829-40. PubMed ID: 15752203
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A simple whole cell based high throughput screening protocol using Mycobacterium bovis BCG for inhibitors against dormant and active tubercle bacilli.
    Khan A, Sarkar D.
    J Microbiol Methods; 2008 Apr 23; 73(1):62-8. PubMed ID: 18328582
    [Abstract] [Full Text] [Related]

  • 12. Antimycobacterial activity of cerulenin and its effects on lipid biosynthesis.
    Parrish NM, Kuhajda FP, Heine HS, Bishai WR, Dick JD.
    J Antimicrob Chemother; 1999 Feb 23; 43(2):219-26. PubMed ID: 11252327
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mycolic acid methyltransferase, MmaA4, is necessary for thiacetazone susceptibility in Mycobacterium tuberculosis.
    Alahari A, Alibaud L, Trivelli X, Gupta R, Lamichhane G, Reynolds RC, Bishai WR, Guerardel Y, Kremer L.
    Mol Microbiol; 2009 Mar 23; 71(5):1263-77. PubMed ID: 19183278
    [Abstract] [Full Text] [Related]

  • 15. Pyrazinoic acid decreases the proton motive force, respiratory ATP synthesis activity, and cellular ATP levels.
    Lu P, Haagsma AC, Pham H, Maaskant JJ, Mol S, Lill H, Bald D.
    Antimicrob Agents Chemother; 2011 Nov 23; 55(11):5354-7. PubMed ID: 21876062
    [Abstract] [Full Text] [Related]

  • 16. Reduced expression of antigenic proteins MPB70 and MPB83 in Mycobacterium bovis BCG strains due to a start codon mutation in sigK.
    Charlet D, Mostowy S, Alexander D, Sit L, Wiker HG, Behr MA.
    Mol Microbiol; 2005 Jun 23; 56(5):1302-13. PubMed ID: 15882422
    [Abstract] [Full Text] [Related]

  • 17. Quantitative proteomic analysis of drug-induced changes in mycobacteria.
    Hughes MA, Silva JC, Geromanos SJ, Townsend CA.
    J Proteome Res; 2006 Jan 23; 5(1):54-63. PubMed ID: 16396495
    [Abstract] [Full Text] [Related]

  • 18. OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice.
    Matsumoto M, Hashizume H, Tomishige T, Kawasaki M, Tsubouchi H, Sasaki H, Shimokawa Y, Komatsu M.
    PLoS Med; 2006 Nov 23; 3(11):e466. PubMed ID: 17132069
    [Abstract] [Full Text] [Related]

  • 19. Stereoselective synthesis of beta-arabino glycosyl sulfones as potential inhibitors of mycobacterial cell wall biosynthesis.
    Ayers B, Long H, Sim E, Smellie IA, Wilkinson BL, Fairbanks AJ.
    Carbohydr Res; 2009 Apr 21; 344(6):739-46. PubMed ID: 19269629
    [Abstract] [Full Text] [Related]

  • 20. Resazurin reduction assays for screening of anti-tubercular compounds against dormant and actively growing Mycobacterium tuberculosis, Mycobacterium bovis BCG and Mycobacterium smegmatis.
    Taneja NK, Tyagi JS.
    J Antimicrob Chemother; 2007 Aug 21; 60(2):288-93. PubMed ID: 17586560
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.